Celotex Safetone Ceiling Tile

Product Description

Celotex Safetone Ceiling Tile was an acoustical ceiling product manufactured and distributed during the period from 1966 through 1973. Designed for installation in commercial, industrial, and institutional settings, Safetone tiles were marketed as a solution for sound dampening and noise control in environments where acoustic management was a practical concern. The tiles were intended for suspended or direct-mount ceiling systems commonly found in factories, warehouses, office buildings, and similar large-scale facilities.

The Celotex brand had a long history in the building materials industry, and the Safetone line represented one of several acoustical products offered under that name during the mid-twentieth century. During this era, asbestos-containing mineral fiber compositions were widely used in ceiling tile manufacturing because they offered fire resistance, dimensional stability, and relatively low material cost. Celotex Safetone tiles were among the products produced within this broader industrial context.

Litigation records document that ASARCO, the mining and smelting corporation with deep involvement in asbestos mineral supply chains, had a material connection to the production and distribution of this product line. ASARCO’s role in supplying raw asbestos fiber to manufacturers of finished building products has been a recurring subject in asbestos personal injury litigation. Although ASARCO is widely recognized as a metals and mining company, records produced in litigation reflect the company’s participation in asbestos-related commerce during the decades when these tiles were in production.


Asbestos Content

Celotex Safetone Ceiling Tile contained chrysotile asbestos as a component of its fiber matrix. Chrysotile, sometimes called white asbestos, is the most commercially prevalent form of asbestos fiber and was extensively incorporated into building products throughout the twentieth century. In ceiling tile applications, chrysotile fibers were typically blended with binders, mineral fillers, and other materials to create a lightweight, rigid panel capable of absorbing sound and meeting basic structural requirements for ceiling installation.

Chrysotile fibers are characterized by their curled, serpentine structure, which distinguishes them from the straighter amphibole asbestos varieties. Despite this structural difference, chrysotile has been classified as a known human carcinogen by major regulatory and public health bodies, including the International Agency for Research on Cancer (IARC) and the U.S. Environmental Protection Agency (EPA). Regulatory frameworks including the Asbestos Hazard Emergency Response Act (AHERA) and OSHA’s asbestos standards apply to chrysotile-containing products and impose requirements for hazard communication, worker protection, and safe handling or removal.

Plaintiffs alleged in litigation that the chrysotile asbestos present in Safetone tiles was capable of releasing respirable fibers during normal product handling, installation, cutting, scoring, and particularly during any later disturbance, maintenance, or removal activities. The friable nature of acoustical ceiling tile materials — products designed with a porous, fiberboard-like composition — meant that physical manipulation of the tiles could cause fiber release without the application of significant mechanical force.


How Workers Were Exposed

Industrial workers generally represent the population documented in connection with occupational exposure to Celotex Safetone Ceiling Tile. Exposure pathways in industrial settings were varied and could occur at multiple points across a product’s service life.

During installation, workers cut tiles to fit around structural elements such as pipes, conduit, ductwork, and support columns. Scoring, snapping, sawing, and sanding were all common methods of trimming acoustical ceiling tiles to size. Each of these activities generated dust that, in a product containing chrysotile asbestos, would include respirable asbestos fibers. Workers performing this work in the 1966–1973 production period typically did so without respiratory protection specifically designed for asbestos, as OSHA’s asbestos permissible exposure limits and related regulatory requirements were still in their formative stages during much of this era.

Beyond initial installation, industrial workers were also exposed when existing tile systems were disturbed during renovation, repair, or equipment maintenance. In industrial facilities, overhead work is common — plumbers, electricians, pipefitters, millwrights, and general maintenance personnel frequently accessed ceiling spaces to service mechanical systems. Lifting, moving, or breaking through asbestos-containing ceiling tiles in the course of this work could liberate fibers into the breathing zone of the worker performing the task, as well as bystanders working in the same area.

Plaintiffs alleged that manufacturers and distributors of asbestos-containing ceiling products, including those within ASARCO’s commercial orbit, were aware or should have been aware of the hazards associated with asbestos fiber inhalation during the production years at issue. Litigation records document contentions that adequate warnings were not provided to workers, employers, or downstream purchasers, leaving those who handled or worked near these products without the information necessary to take protective measures.

Diseases associated with occupational asbestos exposure that have been documented in litigation involving ceiling tile products include mesothelioma, asbestos-related lung cancer, asbestosis, and pleural disease. Mesothelioma — a malignancy of the lining of the lungs, abdomen, or heart — is considered a signature asbestos-related disease and has appeared prominently in claims involving installers and maintenance workers exposed to asbestos building products.


There is no established asbestos bankruptcy trust fund associated with this product. Claims related to Celotex Safetone Ceiling Tile and the role of ASARCO in its production and distribution are addressed through the civil litigation system rather than through a structured trust fund claims process.

It should be noted that ASARCO did establish an asbestos personal injury trust as part of its bankruptcy reorganization proceedings. Individuals considering whether that trust or any related entity applies to their specific exposure circumstances should consult with a qualified asbestos attorney, as trust eligibility depends on the specific nature of the claimant’s exposure, the products at issue, and the documented connection between those products and the trust’s defined covered claims.

For individuals whose claims fall outside the scope of any applicable trust, civil litigation remains the primary avenue for legal remedy. Litigation records document that plaintiffs have brought claims in multiple jurisdictions against parties in the asbestos supply chain, including both manufacturers of finished products and suppliers of raw asbestos fiber. Plaintiffs alleged that negligence, failure to warn, and in some cases strict product liability theories supported recovery for asbestos-related injuries connected to ceiling tile products.

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions who have a history of working with or around ceiling tiles during the 1966–1973 production period — or during later disturbance or removal of tiles installed during that era — are encouraged to seek legal counsel from attorneys experienced in asbestos personal injury litigation. Documentation of work history, job sites, and product identification is important to the development of any potential claim.